NCT02117141已完成1 期
A Pilot Study in Healthy Volunteers to Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release (HC-ER) Capsules, in Both Fed and Fasted States
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 12
- 主要终点
- Assess the rate and extent of absorption of hydrocodone from a 20 mg HC-ER capsule in both fed and fast states
研究概览
简要总结
- Assess the rate and extent of absorption of hydrocodone from a 20 mg HC-ER capsule in both fed and fasted states
- Evaluate the safety and tolerability of the test compound administered orally
详细描述
Safety parameters assessed included medical history, physical examination, vital signs, 12-lead ECGs, clinical laboratory testing and adverse event assessment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy Volunteers.
- •Aged greater than 18 and less than 45 years.
- •Were medically healthy with no clinically significant abnormality on the basis of medical history, physical examination and laboratory evaluations
- •Volunteer consented to participate in the study.
- •Female volunteers were included if they were surgically sterile, or using an acceptable method of birth control defined as either oral, injectable, implantable, or barrier methods of contraception (ie, diaphragm with spermicidal cream, intrauterine device (IUD) with spermicidal cream or condom with spermicidal cream).
排除标准
- •Participants were in a clinical trial within the previous 90 days or participants in a narcotic analgesic study within the previous 12 months.
- •Deviation in excess of 10% from the ideal body weight for height according to the Metropolitan Life Insurance Tables (1983 edition).
- •History of drug or alcohol abuse at any time in the past
- •History of hypersensitivity to the study drug or similar compounds or to acetaminophen.
- •Therapeutic use (for any reason) of narcotic analgesics within the previous year.
- •Subjects who used tricyclic antidepressants or monoamine oxidase inhibitors at any time in the past.
- •Subjects with a history of, or clinical signs suggestive of, chronic obstructive airways disease.
- •Receipt of any prescription medication (except birth control) within 2 weeks prior to entry into the study or receipt of non-prescription or over-the-counter medication within one week of study commencement. (Vitamin supplements were acceptable).
- •Blood donation within the 90 days previous to study entry.
- •Female volunteers with a positive serum pregnancy test, or at risk of becoming pregnant during the study.
- •Volunteers with a history of smoking (must not have smoked within the last 6 months).
- •Volunteers with any clinical/biochemical impairment of liver function, or receipt of known hepatic enzyme inducing or inhibiting agents within 30 days prior to entry into the study.
- •History or presence of significant hepatic, renal, endocrine, cardiac, nervous, gastrointestinal, pulmonary or metabolic disorders.
- •Any condition or history that the investigator considered might increase the risk to the volunteer or interfere with the evaluation of data.
研究组 & 干预措施
HC-ER 20 mg capsule (fasted)
Experimental
Single oral dose of a HC-ER 20 mg capsule (fasted)
干预措施: HC-ER 20 mg capsule (fasted) (Drug)
HC-ER 20 mg capsule (fed)
Experimental
Single oral dose of HC-ER 20mg capsule (fed)
干预措施: HC-ER 20 mg capsule (fed) (Drug)
结局指标
主要结局
Assess the rate and extent of absorption of hydrocodone from a 20 mg HC-ER capsule in both fed and fast states
时间窗: Day 1-2
次要结局
未报告次要终点
研究者
相似试验
已完成
3 期
Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of TimeChronic PainNCT01240863Teva Branded Pharmaceutical Products R&D, Inc.391
已完成
1 期
Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release FormulationHealthyNCT01677039Pfizer19
已完成
1 期
Food Effect Study of Codeine SulfatePainNCT01009892Roxane Laboratories36
已完成
1 期
Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed ConditionHealthyNCT00939835Torrent Pharmaceuticals Limited
已完成
1 期
Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 CapsuleHealthyNCT01548157Hanmi Pharmaceutical Company Limited28